Surmodics Statistics
Total Valuation
Surmodics has a market cap or net worth of $535.16 million. The enterprise value is $530.43 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Surmodics has 14.27 million shares outstanding. The number of shares has increased by 0.86% in one year.
Shares Outstanding | 14.27M |
Shares Change (YoY) | +0.86% |
Shares Change (QoQ) | -0.08% |
Owned by Insiders (%) | 4.31% |
Owned by Institutions (%) | 73.92% |
Float | 11.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.38 |
Forward PS | 3.92 |
PB Ratio | 4.53 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.39 |
EV / EBITDA | 431.25 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.28.
Current Ratio | 3.98 |
Quick Ratio | 3.08 |
Debt / Equity | 0.28 |
Debt / EBITDA | 11.72 |
Debt / FCF | n/a |
Interest Coverage | -2.11 |
Financial Efficiency
Return on equity (ROE) is -1.21% and return on invested capital (ROIC) is -3.14%.
Return on Equity (ROE) | -1.21% |
Return on Assets (ROA) | -2.55% |
Return on Capital (ROIC) | -3.14% |
Revenue Per Employee | $321,332 |
Profits Per Employee | -$3,721 |
Employee Count | 376 |
Asset Turnover | 0.66 |
Inventory Turnover | 1.54 |
Taxes
Income Tax | -7.76M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.15% in the last 52 weeks. The beta is 1.20, so Surmodics's price volatility has been higher than the market average.
Beta (5Y) | 1.20 |
52-Week Price Change | +31.15% |
50-Day Moving Average | 38.87 |
200-Day Moving Average | 35.90 |
Relative Strength Index (RSI) | 31.98 |
Average Volume (20 Days) | 227,073 |
Short Selling Information
The latest short interest is 317,696, so 2.23% of the outstanding shares have been sold short.
Short Interest | 317,696 |
Short Previous Month | 323,570 |
Short % of Shares Out | 2.23% |
Short % of Float | 2.81% |
Short Ratio (days to cover) | 1.35 |
Income Statement
In the last 12 months, Surmodics had revenue of $120.82 million and -$1.40 million in losses. Loss per share was -$0.10.
Revenue | 120.82M |
Gross Profit | 97.67M |
Operating Income | -7.48M |
Pretax Income | -9.16M |
Net Income | -1.40M |
EBITDA | 1.23M |
EBIT | -7.48M |
Loss Per Share | -$0.10 |
Full Income Statement Balance Sheet
The company has $38.18 million in cash and $33.45 million in debt, giving a net cash position of $4.72 million or $0.33 per share.
Cash & Cash Equivalents | 38.18M |
Total Debt | 33.45M |
Net Cash | 4.72M |
Net Cash Per Share | $0.33 |
Equity (Book Value) | 118.14M |
Book Value Per Share | 8.28 |
Working Capital | 60.16M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.16 million and capital expenditures -$3.70 million, giving a free cash flow of -$5.86 million.
Operating Cash Flow | -2.16M |
Capital Expenditures | -3.70M |
Free Cash Flow | -5.86M |
FCF Per Share | -$0.41 |
Full Cash Flow Statement Margins
Gross margin is 80.84%, with operating and profit margins of -6.19% and -1.16%.
Gross Margin | 80.84% |
Operating Margin | -6.19% |
Pretax Margin | -7.58% |
Profit Margin | -1.16% |
EBITDA Margin | 1.02% |
EBIT Margin | -6.19% |
FCF Margin | -4.85% |
Dividends & Yields
Surmodics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.86% |
Shareholder Yield | -0.86% |
Earnings Yield | -0.26% |
FCF Yield | -1.09% |
Analyst Forecast
The average price target for Surmodics is $43.00, which is 14.64% higher than the current price. The consensus rating is "Hold".
Price Target | $43.00 |
Price Target Difference | 14.64% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 7, 2000. It was a forward split with a ratio of 2:1.
Last Split Date | Dec 7, 2000 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Surmodics has an Altman Z-Score of 6.34 and a Piotroski F-Score of 1.
Altman Z-Score | 6.34 |
Piotroski F-Score | 1 |